The latest closing stock price for Ultragenyx Pharmaceutical as of September 19, 2024 is 58.78.
An investor who bought $1,000 worth of Ultragenyx Pharmaceutical stock at the IPO in 2014 would have $391 today, roughly 0 times their original investment - a 3.05% compound annual growth rate over 11 years.
The all-time high Ultragenyx Pharmaceutical stock closing price was 177.39 on December 23, 2020.
The Ultragenyx Pharmaceutical 52-week high stock price is 60.37, which is 2.7% above the current share price.
The Ultragenyx Pharmaceutical 52-week low stock price is 31.52, which is 46.4% below the current share price.
The average Ultragenyx Pharmaceutical stock price for the last 52 weeks is 44.40.
An investor who bought $1,000 worth of Ultragenyx Pharmaceutical stock at the IPO in 2014 would have $391 today, roughly 0 times their original investment - a 3.05% compound annual growth rate over 11 years.
The all-time high Ultragenyx Pharmaceutical stock closing price was 177.39 on December 23, 2020.
The Ultragenyx Pharmaceutical 52-week high stock price is 60.37, which is 2.7% above the current share price.
The Ultragenyx Pharmaceutical 52-week low stock price is 31.52, which is 46.4% below the current share price.
The average Ultragenyx Pharmaceutical stock price for the last 52 weeks is 44.40.